Bristol-Myers Squibb (BMY)
$46.98
1.23 (2.69%)
BMY Stock Quote Delayed 15 Minutes
Previous Close
$46.98
Market Cap
76.79B
PE Ratio
82.42
EPS
0.57
Volume (Avg. Vol.)
9.63M
Day's Range
45.78 - 47.06
52-Week Range
42.48 - 63.69
Dividend & Yield
1.60 (3.41%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Risk-Takers Have a Reasonable Shot with BMY Stock
Political pressures regarding drug pricing and Bristol-Myers’ disappointing clinical trails have contributed to a disappointing performance for BMY stock. Still, much of this bearishness could be priced in already.
Fear Around Bristol-Myers Squibb Stock is Starting to Fade
BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.
Stock Market Today: The Tariff Man Is Back
Investors were looking at a strong rally in the stock market today, until the president tweeted about incoming tariff increases against China.
Stock Market Today: Boeing, Tesla Tumble on More Worries
Stock were hit on Thursday as investors try to parse through a deluge of earnings results. Here's what moved the stock market today.
Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance
Bristol-Myers Squibb earnings for the second quarter of the year have BMY stock on the move Thursday after it beat estimates.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
4 Drug Stocks Getting Smashed
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.
5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
3 Big Stock Charts for Tuesday: MGM Resorts, Electronic Arts and Advance Auto Parts
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.
Nasdaq Today: Celgene, Ulta, Caesars’ Buyout
Celgene and Bristol-Myers Squibb stocks took a hit, video games rallied and Caesars Entertainment entered into a $17.3 billion merger. Here's the Nasdaq Today report.
5 Top Stock Trades for Tuesday: CELG, BMY, CZR
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.
Bristol-Meyers Squibb News: Why BMY Stock Is Falling Today
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
2 Dividend Stocks to Buy That Are Better Than 3M Stock
MMM stock has fallen 25% in the past six weeks since announcing weaker-than-expected Q1 earnings. 3M stock has been weak since then.
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Bristol-Myers Squibb Earnings: BMY Stock Pops on Q1 Beat
Bristol-Myers Squibb earnings for the first quarter of 2019 have BMY stock up Thursday on an earnings per share and revenue beat.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
